These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors. Kang J, Park JW, Won JK, Bae JM, Koh J, Yim J, Yun H, Kim SK, Choi JY, Kang HJ, Kim WS, Shin JH, Park SH. Diagn Pathol; 2020 Sep 21; 15(1):114. PubMed ID: 32957984 [Abstract] [Full Text] [Related]
3. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma. Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR. Am J Surg Pathol; 2018 Jun 21; 42(6):791-798. PubMed ID: 29553955 [Abstract] [Full Text] [Related]
4. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma. Kao YC, Fletcher CDM, Alaggio R, Wexler L, Zhang L, Sung YS, Orhan D, Chang WC, Swanson D, Dickson BC, Antonescu CR. Am J Surg Pathol; 2018 Jan 21; 42(1):28-38. PubMed ID: 28877062 [Abstract] [Full Text] [Related]
5. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors. Csanyi-Bastien M, Lanic MD, Beaussire L, Ferric S, François A, Meseure D, Jardin F, Wassef M, Ruminy P, Laé M. Am J Surg Pathol; 2021 Nov 01; 45(11):1487-1498. PubMed ID: 33899788 [Abstract] [Full Text] [Related]
6. NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods. Surrey LF, Davis JL. Cancer Genet; 2022 Jan 01; 260-261():6-13. PubMed ID: 34794069 [Abstract] [Full Text] [Related]
7. Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions. Antonescu CR, Dickson BC, Swanson D, Zhang L, Sung YS, Kao YC, Chang WC, Ran L, Pappo A, Bahrami A, Chi P, Fletcher CD. Am J Surg Pathol; 2019 Oct 01; 43(10):1384-1391. PubMed ID: 31219820 [Abstract] [Full Text] [Related]
8. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature. Suurmeijer AJH, Xu B, Torrence D, Dickson BC, Antonescu CR. Genes Chromosomes Cancer; 2024 Jan 01; 63(1):e23205. PubMed ID: 37782551 [Abstract] [Full Text] [Related]
9. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions. Brčić I, Godschachner TM, Bergovec M, Igrec J, Till H, Lackner H, Scheipl S, Kashofer K, Brodowicz T, Leithner A, Szkandera J, Liegl-Atzwanger B. Mod Pathol; 2021 Feb 01; 34(2):396-407. PubMed ID: 32860002 [Abstract] [Full Text] [Related]
10. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST). Atiq MA, Davis JL, Hornick JL, Dickson BC, Fletcher CDM, Fletcher JA, Folpe AL, Mariño-Enríquez A. Mod Pathol; 2021 Jan 01; 34(1):95-103. PubMed ID: 32669612 [Abstract] [Full Text] [Related]
11. A novel TMTC2-NTRK3 fusion in undifferentiated high-grade pleomorphic sarcoma. Bai C, Zhang L, Wang Y, You X, Ju Y, Sun T, Fan Z. J Cancer Res Clin Oncol; 2022 Oct 01; 148(10):2933-2937. PubMed ID: 35933643 [Abstract] [Full Text] [Related]
12. Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls. Moura MS, Costa J, Velasco V, Kommoss F, Oliva E, Le Loarer F, McCluggage WG, Razack R, Treilleux I, Mills A, Longacre T, Devouassoux-Shisheboran M, Hostein I, Azmani R, Blanchard L, Hartog C, Soubeyran I, Khalifa E, Croce S. Histopathology; 2024 Feb 01; 84(3):451-462. PubMed ID: 37988282 [Abstract] [Full Text] [Related]
13. Fluorescent In Situ Hybridization Must be Preferred to pan-TRK Immunohistochemistry to Diagnose NTRK3-rearranged Gastrointestinal Stromal Tumors (GIST). Castillon M, Kammerer-Jacquet SF, Cariou M, Costa S, Conq G, Samaison L, Douet-Guilbert N, Marcorelles P, Doucet L, Uguen A. Appl Immunohistochem Mol Morphol; 2021 Sep 01; 29(8):626-634. PubMed ID: 33758144 [Abstract] [Full Text] [Related]
14. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements. Tsai JW, Lee JC, Hsieh TH, Huang SC, Lee PH, Liu TT, Kao YC, Chang CD, Weng TF, Li CF, Lin JC, Liang CW, Su YL, Chang IY, Wang YT, Chang NY, Yu SC, Wang JC, Huang HY. Mod Pathol; 2022 Jul 01; 35(7):911-921. PubMed ID: 35149769 [Abstract] [Full Text] [Related]
15. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing. Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A. Pathology; 2022 Feb 01; 54(1):55-62. PubMed ID: 34518039 [Abstract] [Full Text] [Related]
16. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions. Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA. Am J Surg Pathol; 2017 Nov 01; 41(11):1547-1551. PubMed ID: 28719467 [Abstract] [Full Text] [Related]
17. S100 and Pan-Trk Staining to Report NTRK Fusion-Positive Uterine Sarcoma: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting. Chiang S. Int J Gynecol Pathol; 2021 Jan 01; 40(1):24-27. PubMed ID: 33290352 [Abstract] [Full Text] [Related]
18. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma. Yamamoto H, Nozaki Y, Sugii A, Taguchi K, Hongo T, Jiromaru R, Sato M, Nakano T, Hashimoto K, Fujiwara M, Oda Y. Hum Pathol; 2021 Mar 01; 109():37-44. PubMed ID: 33301751 [Abstract] [Full Text] [Related]